Ambrose Allison
SEC CIK 2047381 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| UPB | Upstream Bio, Inc. | GC | 15.6K | — | $9,985 | 4 | 2026-01-02 | 2026-09-16 |
Most active insiders at UPB, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Sutherland Everett Rand | CEO, Dir | — | $43.7K |
| 2 | Deykin Aaron | Chief Medical Off | — | $18.7K |
| 3 | GRAY MICHAEL | CFO, COO | — | $17.8K |
| 4 | Houghton Adam | Chief Business Off | — | $14.6K |
| 5 | Ambrose Allison | GC | — | $9,985 |
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-17 16:05 | 2026-09-16 | UPB | Upstream Bio, Inc. | Ambrose Allison | GC | S - Sale | $5.49 | -485 | 15.6K | -3% | -$2,663 | |
| 2026-06-17 16:05 | 2026-06-16 | UPB | Upstream Bio, Inc. | Ambrose Allison | GC | S - Sale | $6.10 | -477 | 16.0K | -3% | -$2,910 | |
| 2026-03-17 | 2026-03-16 | UPB | Upstream Bio, Inc. | Ambrose Allison | GC | S - Sale | $9.29 | -475 | 16.5K | -3% | -$4,413 | |
| D | 2026-01-06 | 2026-01-02 | UPB | Upstream Bio, Inc. | Ambrose Allison | GC | A - Grant | $0.00 | +17.0K | 17.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations